Erekle Biosciences Private Limited
About Erekle Biosciences Private Limited
Data last updated:
Erekle Biosciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC319283. Its GSTIN is 10AAECE6814D1Z9 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Masood Azhar and Parvez Alam.
Its last annual general meeting (AGM) was held on 30 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at K II – 849 – B Sangam Vihar, New Delhi, Delhi, India – 110062.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Erekle Biosciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressK II – 849 – B Sangam Vihar, New Delhi, Delhi, India – 110062
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Erekle Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Erekle Biosciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Erekle Biosciences Private Limited, buy the company report.
Financials of Erekle Biosciences Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Erekle Biosciences Private Limited, buy the company report.
Board of directors of Erekle Biosciences Private Limited
Erekle Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Masood Azhar Also directs: Mediden Healthcare Solutions LLP | Director | 15 Jun 2017 | 9 Years 4 Months | Current |
| Parvez Alam Also directs: Trusthera Pharmaceuticals Private Limited | Director | 10 Dec 2021 | 4 Years 10 Months | Current |
Auditor
Erekle Biosciences Private Limited is audited by M A K S S & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M A K S S & ASSOCIATES | FY 2020 | 021083C |
Shareholding
The shareholding of Erekle Biosciences Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Erekle Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Erekle Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Erekle Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Erekle Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECE6814D1Z9 | Bihar | Active | 18 Aug 2018 |
To see the full GST registrations and return filing status of Erekle Biosciences Private Limited, buy the company report.
Recent activity
Erekle Biosciences Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Parvez Alam was appointed as Director on 10 Dec 2021.
Frequently asked questions
Erekle Biosciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 June 2017 (9+ years old) and is registered under CIN U74999DL2017PTC319283.
Erekle Biosciences has 2 current directors:
- Masood Azhar - Director
- Parvez Alam - Director
The latest financial statements of Erekle Biosciences on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 September 2020. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Erekle Biosciences is 10AAECE6814D1Z9, registered in Bihar.
The CIN (Corporate Identification Number) of Erekle Biosciences is U74999DL2017PTC319283. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Erekle Biosciences was incorporated on 15 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Parvez Alam was appointed as Director on 10 Dec 2021. Washim Khan ceased to be Director on 10 Dec 2021. Masood Azhar was appointed as Director on 15 Jun 2017.
The registered office of Erekle Biosciences is at K II – 849 – B Sangam Vihar, New Delhi, Delhi, India – 110062.
Erekle Biosciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Erekle Biosciences is active non-compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
